Key findings of our research are:
Research (lead identification) is generally not outsourced, and discovery (lead generation and optimization) outsourcing is evolving in India. India scores very high on clinical data management and site management outsourcing. The costs of clinical trials in R&D can be reduced by 35%-50% by using contract research organizations (CROs) in India.
Bangalore, Hyderabad and Mumbai have emerged as the hubs for pharmaceutical activities. The CRO market in India has been growing at a fast pace since 2001 and is expected to cross the $1 billion mark by 2010.
Besides doing in-house offshore R&D in India, many leading pharma companies are also outsourcing R&D, manufacturing and IT services. Outsourcing of R&D, IT and manufacturing by pharmaceutical companies started in the late 1990s.
Since clinical development, discovery and non-clinical services account for almost 85% of the R&D budget, offshoring and outsourcing makes a big impact on the R&D budget.
To download a report on this topic, click here.
